BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27599383)

  • 1. Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration.
    Lee JJ; Nam S; Park JH; Lee SY; Jeong JY; Lee JY; Kang WS; Yoon IS; Kim DD; Cho HJ
    J Colloid Interface Sci; 2016 Dec; 484():146-154. PubMed ID: 27599383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of polymer matrix-free nanocomposites based on Angelica gigas Nakai extract and their application to breast cancer therapy.
    Lee SY; Lee JJ; Nam S; Kang WS; Yoon IS; Cho HJ
    Colloids Surf B Biointerfaces; 2017 Nov; 159():781-790. PubMed ID: 28886514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydopamine-coated nanocomposites of Angelica gigas Nakai extract and their therapeutic potential for triple-negative breast cancer cells.
    Nam S; Lee SY; Kim JJ; Kang WS; Yoon IS; Cho HJ
    Colloids Surf B Biointerfaces; 2018 May; 165():74-82. PubMed ID: 29454167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids incorporated colloidal systems for the delivery of Angelica gigas Nakai extract.
    Lee JJ; Park JH; Lee JY; Jeong JY; Lee SY; Yoon IS; Kang WS; Kim DD; Cho HJ
    Colloids Surf B Biointerfaces; 2016 Apr; 140():239-245. PubMed ID: 26764107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects.
    Piao J; Lee JY; Weon JB; Ma CJ; Ko HJ; Kim DD; Kang WS; Cho HJ
    PLoS One; 2015; 10(4):e0124447. PubMed ID: 25915423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angelica gigas Nakai extract-loaded fast-dissolving nanofiber based on poly(vinyl alcohol) and Soluplus for oral cancer therapy.
    Nam S; Lee JJ; Lee SY; Jeong JY; Kang WS; Cho HJ
    Int J Pharm; 2017 Jun; 526(1-2):225-234. PubMed ID: 28478278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
    Li L; Zhang J; Xing C; Kim SH; Lü J
    Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
    Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
    Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.
    Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J
    Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of
    Kim SJ; Ko SM; Choi EJ; Ham SH; Kwon YD; Lee YB; Cho HY
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29701699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
    Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
    Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
    Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
    Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Angelica gigas Nakai on the production of decursin- and decursinol angelate-enriched eggs.
    Fontamillas GAD; Kim SW; Kim HU; Kim SJ; Kim JG; Park TS; Park BC
    J Sci Food Agric; 2019 Apr; 99(6):3117-3123. PubMed ID: 30536922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai.
    Kim KM; Kim MJ; Kang JS
    J Microbiol Biotechnol; 2009 Dec; 19(12):1569-72. PubMed ID: 20075620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.
    Zhang J; Li L; Hale TW; Chee W; Xing C; Jiang C; Lü J
    PLoS One; 2015; 10(2):e0114992. PubMed ID: 25695490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Decursin and
    Lee TK; Kim B; Kim DW; Ahn JH; Sim H; Lee JC; Yang GE; Her Y; Park JH; Kim HS; Sim TH; Lee HS; Won MH
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32823713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds.
    Zhang J; Li L; Jiang C; Xing C; Kim SH; Lü J
    Anticancer Agents Med Chem; 2012 Dec; 12(10):1239-54. PubMed ID: 22583405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities.
    Reddy CS; Kim SC; Hur M; Kim YB; Park CG; Lee WM; Jang JK; Koo SC
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29215592
    [No Abstract]   [Full Text] [Related]  

  • 19. Biopharmaceutical characterization of decursin and their derivatives for drug discovery.
    Mahat B; Chae JW; Baek IH; Song GY; Song JS; Ma JY; Kwon KI
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1523-30. PubMed ID: 23003006
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jeon YJ; Shin JI; Lee S; Lee YG; Kim JB; Kwon HC; Kim SH; Kim I; Lee K; Han YS
    Biomed Res Int; 2018; 2018():6716547. PubMed ID: 30155480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.